Platform Technologies

SBH has a wide range of Biomarker Platforms

Our many state of the art platforms allow SBH to provide the highest quality services to our customers.  

Our platforms include:

 


AccuriBD Accuri C6

BD Biosciences
  • Flow cytometry
  • Cell Analyzer
  • Detection of FITC, PE, PerCP-Cy5.5 and APC
  • Learn More...

CLARIOstarCLARIOstar

BMG LABTECH
  • AlphaScreen / AlphaLISA 
  • HTRF® & TR-FRET
  • UV/vis , Fluorescence and luminescence reader
  • Learn More...


ellaElla

ProteinSimple 
  • Simple Plex 
  • Immunoassay technology / Lower cross-reactivity
  • 8 Biomarkers / 25 ul sample
  • Learn More...

Isolight

IsoLight

IsoPlexis
  • Biomarker analysis
  • Cellular Proteomics system 
  • Single-cell secreted protein analysis
  • Learn More...

sw_jess_front

Jess

ProteinSimple
  • Protein separation and immunodetection
  • Automatic Western Blot
  • Chemiluminescence and Fluorescence detection
  • Learn More...

lum200_top
Luminex® 200

Luminex
  • MultiAnalyte Profiling (MAP)
  • xMAP Technology
  • Custom Development 
  • Learn More...

PeggySuePeggy Sue

ProteinSimple
  • Automated Capillary Immunoassay
  • Protein separation by size and Charge
  • Up to 96 samples / run
  • Learn More...


sq-120-147x144QuickPlex SQ 120

MSD
  • Automated multiplex
  • 5-log dynamic range
  • Electrochemiluminescence (ECL)
  • Learn More...

 

SMCxPRO SMCxPRO

MilliporeSigma 
  • Ultrasensitive immunoassay platform
  • Multiplexing analysis of Proteins
  • Single Molecule Counting Technology
  • Learn More...


StepOnePlus2

StepOne PCR

Applied Biosystems

wesWES

ProteinSimple
  • Protein Analysis
  • Automatic Western Blot
  • Highly reproducible immunoassay quantitation
  • Learn More...

 

 

BD Accuri™ C6 

Flow Cytometry

AccuriFlow cytometry is a laser based, biophysical technology employed in cell counting, sorting, and biomarker detection and protein engineering, by suspending cells in a stream of fluid and passing them by an electronic detection apparatus. It allows simultaneous multi-parametric analysis of the physical and/or chemical characteristics of up to thousands of particles per second. SBH Sciences houses a BD Accuri™ C6 flow cytometer to assist us with your research needs and questions.

The system is equipped with a blue laser and a red laser, two scatter detectors, and four fluorescence detectors with interference filters optimized for the detection of FITC, PE, PerCP-Cy™5.5, and APC.

Flow cytometry can be a useful tool in many areas of research: immunology, cell and cancer biology, and microbiology. Additionally, Flow cytometry provides a powerful method for investigating cell signaling because the cells do not need to be lysed which is a prerequisite for many techniques. Researchers can first treat cells in a myriad of ways, then fix, stain with conjugated antibodies against cell surface and/or intracellular proteins (permeabilization required), and analyze the cells using flow cytometry.

flow3

SBH Sciences scientists also have access to the Attune Nxt Acoustic Focusing Cytometer (Invitrogen) located in the Innovation Lab at ABI-LAB II. This flow cytometer has four lasers, blue 488nm, red 635 nm, violet 405 nm and yellow 561 nm and can perform compensation for your multi-fluorochrome experiments. A recent addition to the Innovation Lab is the Attune CytPix Flow Cytometer which only has two lasers , red and blue, but has a high-speed brightfield camera which captures sharp images of your cells as they pass through the flow cell helping you analyze only single cells and not doublets or debris. Below left is a histogram from a FACS analysis of C6 cells stained with 5 ug/ml rabbit anti-rat IL-1beta. An incremental increase in mean fluorescence was detected as the antibody concentration increased from 1 ug/ml to 5 ug/ml (table).

FACS_analysis FACS_analysis2

At SBH Sciences we have also performed FACS analyses to assist clients with their cell cycle, drug testing and quality assurance experiments. The histogram on the right is from Jurkat cells stained with PI/Rnase staining buffer. We also have detected numerous cytokine targets both with intracellular and surface staining and obtained high signal to noise ratios. Please contact us if you would need assistance with your FACS analysis experiments.

 

^ Top


 

 

CLARIOstar

 

AlphaScreen® and AlphaLISA®

SBH Sciences has a newly acquired instrument, the CLARIOstar, to bring you even more versatility and assay options.

CLARIOstar

The CLARIOstar is BMG LABTECH's newest microplate reader and it is the only reader on the market available with the three technologies required to run any assay in your laboratory; patent-pending LVF monochromators, UV/vis spectrometer, and high transmission optical filters. The CLARIOstar does not compromise in sensitivity or flexibility, instead providing you with the tools to choose what is needed for your application.

Time Resolved Fluorescence (HTRF® & TR-FRET)
Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) is a special form of resonance energy transfer (FRET) in which long emission fluorophores (lanthanides) are used as donors. The comparison measurement of the two emitted wavelengths over time is calculated for a TR-FRET response. The most common TR-FRET assays include HTRF®, LanthaScreen®, LANCE®, and Transcreener® ADP2 TR-FRET Red Assay.

AlphaScreen®
Amplified Luminescent Proximity Homogeneous Assay (Alpha) Technology, commonly known as AlphaScreen® and AlphaLISA®, is a bead-based detection mode which measures the interaction of two molecules bioconjugated to donor and acceptor beads. When excited at 680 nm, the donor bead produces singlet oxygen. If the acceptor bead is within a 200 nm distance, the singlet oxygen transfers energy to the donor resulting in production of light between 520 and 620 nm. The amount of produced light is directly proportionate to the amount of bound donor-acceptor beads. AlphaLISA is slightly different from AlphaScreen in that the primary emission occurs at 615nm.

 

^ Top

 


 

 

ELLA Simple Plex Platform

simple_plexSBH Sciences is among the first Contract Research Organizations World Wide that is offering contract services using the Simple Plex Platform (ELLA).

The Simple Plex platform is a transformative immunoassay technology which integrates an innovatively designed microfluidic cartridge with a state-of-the-art analyzer to deliver the most efficient benchtop immunoassay system along with reliable results. It brings a level of automation to the traditional ELISA by providing "sample-to-answer" test results in a sealed disposable cartridge within 1 hour while removing operator related biases. In addition, because of its unique multi-analyte capability with none of the drawbacks of traditional multiplex platforms, this platform has broad applicability in both research and clinical markets. We at SBH Sciences are offering both immunoassy platforms, the Luminex and the Simple Plex Platforms to meet customers' complete workflow in their research and clinical protein applications.

Customized Simple Plex cartridges can assay up to 8 analytes simultaneously in 75 minutes and require only 25ul of sample. All Simple Plex assays are fully validated, highly sensitive (picogram/ml), and feature up to 4 logs of dynamic range.

Simple_Plex_Cartridges

For example, the Simple Plex HEK 293 HCP 3G (SPCKB-OT-007066) assay on Ella offers broad detection coverage of the most relevant host cell proteins (HCPs).

SBH_welcome

SBH Sciences is offering an accurate and sensitive measurement of PD-L1 using the Simple Plex. More than 175 validated analyses can be tested at SBH Sciences using this platform. Full list is available at:  
http://www.proteinsimple.com/simple_plex_assays.html

Validated Simple Plex (ELLA) Analytes Available for Immediate Use.

 

^ Top


 

 

IsoLight

 

IsoPlexis Single-Cell Functional Proteomics


SBH Sciences in conjunction with Isoplexis is offering biomarker analysis using the Isolight.
Please contact us with any question. We would be delighted to work with you.

Isolight

High-Impact Applications


IsoPlexis' highly multiplexed single-cell and bulk proteomic solutions provide comprehensive immune profiling for a range of diseases and research areas, from infectious disease to cell therapy and cancer immunology. Available for human, mouse, and non-human primate model systems, IsoPlexis' solutions provide a flexible platform that can support a variety of applications from early-stage R&D through clinical trials. A detailed list of panels is available here.

Isolight_singlecellsecretome

 

Isolight_singlecellsignaling

 

Isolight_codeplex

 

Single-Cell Secretome Single-Cell Signaling      CodePlex     



IsoPlexis' Unique Biology

IsoPlexis' Functional Proteomics platform reveals the rare subsets of highly-polyfunctional cells that simultaneously secrete multiple cytokines. These highly functionally active cells have been shown to be predictive of patient response and disease progression in vivo. Traditional technologies can estimate cellular function at the population level, but these estimates do not reflect differences in that population's function. IsoPlexis' system is the only technology able to phenotype each immune cell by its extracellular function, revealing the unique power of the individual cell.

Learn More

Isolight_supercell

The Functional Cell Library

IsoPlexis developed a new library of cells characterized by functional proteomics to complement the genomic-based Human Cell Atlas. The Functional Cell Library (FCL) adds a unique layer of proteomic data on the wide range of superpowered immune and tumor cell types uniquely identified by IsoPlexis' Single-Cell Functional Proteomics.

Unlock The Functional Cell Library

Please contact us so we can discuss your specific needs, we will be happy to assist you.

 

^ Top


 

 

 

Luminex® 200

 

Luminex / Multiplex Services

lum200_topMULTIPLEX
Custom Development and Testing Services of MultiAnalyte Profiling (MAP)

SBH Sciences is offering Multiplex Cytokines Custom Development and Testing Services based on our Cytokine expertise and the Luminex® xMAP Technology. The xMAP platform technology allows simultaneous quantification of MultiAnalyte Profiling including cytokines / chemokines / biomarkers in cell culture and biological samples. We are offering tailor-made assay development of Multi Arrays usually based on already available commercial assays as well as additional of new innovative biological markers. We will develop the assay and will evaluate, verify and optimize the dynamic range, signal linearity, assay specificity and will ensure Multiplex compatibility. We are also providing Customer Sample Testing Services.

Our custom assays can be tailor-made for many applications including: Cancer Markers, Cardiac Markers, Growth Factors and Transcription Factors. It might assist to assess the mechanism of action for monoclonal antibodies, recombinant proteins, small molecule therapeutics across a range of disease states including cardiovascular, inflammation, immunology, oncology, and CNS disorders.

Our expertise in the production and purification will be applied as well. For example, SBH Sciences can assist you in the isolation of specific biomarker from natural sources or produce it as a recombinant protein while simultaneously, we will also develop your specific MultiAnalyte Method.

We are using the Luminex® 200™ analyzer (Luminex and Luminex 200 are registered trademarks of Luminex Corporation). We also can perform Cell-Based assays for you samples using over 400 different cell lines. Please see our unique Cytokine Bioassay Services.

Please contact us so we can discuss your specific needs, we will be happy to assist you.

 

Luminex Analytes Tested and Available for Immediate Use

SBH Sciences has performed comprehensive testing on the 58 analytes below with 36 validated assays already completed.

If you need analysis of a biomarker that is not currently available on our list, please contact us. We will be happy to assist you.

Biomarker Validated Human Mouse Potential Biomarker for:
CD40 ligand (soluble)   +   Alzheimer's
chemokine (C-X-C motif)
ligand 1 (CXCL1)
  + + Melanoma
chemokine (C-X-C motif)
ligand 2 (CXCL2)
    + Asthma
EGF   +   Glomerular Disease, Parkinson's Disease
Eotaxin / CCL11 + +   Neurodegenerative Diseases
Eotaxin-3 / CCL26 + +   Churg-Strauss syndrome, Inflammatory Diseases
FGF-basic + +   Renal disease
Flt-3 ligand   +   Gastrointestinal non-Hodgkin's lymphoma
Fractalkine   +   Inflammation, Crohn's Disease
G-CSF     + Cardiovascular
GM-CSF + +   Rheumatoid Arthritis 
GRO   +   Inflammation
ICAM-1 + +   Alzheimer's disease, Inflammation
IFN-alpha   +   Autoimmune diseases
IFN-gamma + +   Autoimmune diseases
IL-1alpha + +   Rheumatoid Arthritis/Alzheimer's 
IL-1RA   +   Auto inflammatory syndrome, inflammatory vascular disease
IL-1beta + + + Inflammation
IL-2 + +   Immune responses
IL-2RA   +   Inflammation
IL-3   +   Hodgkin's disease
IL-4 + + + Allergies/Inflammation
IL-5 + +   Inflammatory Diseases
IL-6 + + + Inflammatory/Immune Responses
IL-7 + +   Hodgkin's disease
IL-8 + +   Cardiovascular disease, Inflammation
IL-9   +   Crohn's disease, Inflammation
IL-10 + + + Autoimmune diseases, Inflammation
IL-12 p40 + + + Autoimmune diseases
IL-12 p70 + +   Autoimmune diseases
IL-13 + +   Asthma
IL-15 + +   Cancer
IL-16     + Whipple Disease
IL-17A + + + Rheumatoid Arthritis/Psoriasis/Multiple Sclerosis
IP-10 + +   Tuberculosis, HIV infection, Alzheimer's
Leptin     + Alzheimer's disease, Vascular, Autoimmune
LIF     + Inflammatory/Immune Responses
MIP-1alpha / CCL3 + +   Inflammatory Responses
MIP-1beta / CCL4 + +   Chronic Inflammation/Liver Damage
MCP-1 / CCL2 + + + Inflammation, Diabetes
MCP-3 / CCL7   +   Inflammation
MCP-4 / CCL13 + +   Asthma
MDC / CCL22 + +   Inflammation
PIGF + +   Early Pregnancy Location
PDGF-AA   +   Renal disease
PDGF-AB/BB   +   Renal disease
RANTES / CCL5   +   Renal disease
TARC / CCL17 + +   Related to thymus
Tie-2 + +   Endothelial diseases
TGF-alpha   +   Menetrier's disease, kidney disease
TNF-alpha  + + + Inflammation, Diabetes, Obesity
TNF-beta + +   Inflammation, antiviral responses
TNF-RI + +   Autoimmune
TNF-RII + +   Autoimmune
VCAM-1 + +   Diabetes, Cardiovascular Disease
VEGF     + Alzheimer's disease
VEGF-A + +   Carcinoma, Breast Cancer
VEGF-D + +   Carcinoma, Breast Cancer

 

^ Top


 

 

 

Automated Western Blot

 

Jess, Peggy Sue, Wes

Automated Western Blot Analysis Services

A major challenge in protein research is obtaining rapid, quantitative, reproducible, high-content information.

Since 2013 SBH Sciences and SBH Diagnostics have offered innovative, automated Simple Western Blot services using the PeggySue, WES and JESS (ProteinSimple) systems. This technology is based on novel protein separation using capillary electrophoresis (CE) and highly accurate immunodetection. Proteins can be separated by size, as in traditional PAGE westerns, or by pI, as in traditional CE or isoelectric focusing.

This service is especially suited to pharmaceutical and biotech companies using traditional western blots in their research, development, and QC labs. Simple Western has applications in vaccine development, kinase inhibitor, cell lysate analysis (from tissue culture or tumors), and the identification and quantitation of tumor-associated proteins in clinical patient samples.

View our Simple Western™ Case Studies on the SBH Diagnostics site.

sw_jess_front

 

PeggySue

 

wes

 

Jess Peggy Sue Wes
 

Benefits of the Automated Western Service

  • Quantitative reproducible protein analysis with CVs under 10%
  • High-throughput capability
  • Ability to multiplex and normalize results to standard proteins
  • Efficient and cost-effective

 

The Simple Western™ Protein Analysis can provide:

  • Protein quantification and characterization
  • Protein Charge Heterogeneity analysis
  • Protein Formulation & Stability Testing
  • Antibody and Antibody Drug-Conjugate Characterization
  • Gel and Blot Documentation
  • Multiplexed Protein Analysis
  • Post-Translational Modification Characterization
  • Evaluation of novel therapeutics against key cancer-associated target proteins in kinase signaling pathways
  • Stratification of patient populations for clinical trials

mws

Size/charge-based characterization of proteins has traditionally been performed by either SDS-PAGE/IEF/Western blot or by capillary electrophoresis (CE). Each technique has advantages; western blotting delivers high sensitivity and specificity, while CE offers high resolution and reproducibility. However, a challenge in obtaining optimal results is the need to preconcentrate or stack enough protein sample before separation. Simple Western is a new size-based or charge-based separation platform that combines the advantages of both Western blotting and CE into a single automated workflow. Optimization of stacking conditions results in a significant increase in both sensitivity and resolution.

Please contact us to discuss your protein separation and detection needs, and how our services can provide solutions.


 

 

^ Top


 

 

MSD QuickPlex SQ 120

 

The QuickPlex SQ 120 is an automated plate reader similar to the LUMINEX and ELLA designed for electrochemiluminescence immunoassays. It has a high sensitivity detection system detecting as low as 0.05pg/mL, a 5-log dynamic range and multiplexing capabilities. The main advantage the QuickPlex SQ 120 has over the ELLA and LUMINEX is its higher throughput. It can read a 96-well plate in 3 min versus Luminex and ELLA which can take 1.5 - 2 hours per plate.

There are 5 different assay types that the QuickPlex SQ 120 can run. The assay styles are R-Plex, S-Plex, T-Plex, U-Plex, and V-Plex. Each has a different optimization such as customization, validation, and ultrasensitive detection.

Please contact us with any inquiry and we would be delighted to assist you.

sq-120-147x144

 

 


 

 

^ Top


 

 

 

SMCxPRO™ Platform from MilliporeSigma

 

Single Molecule Counting (SMC™) for your ultrasensitive biomarker needs

SMCxPRO-1SBH Sciences offers bioanalytical services for biomarker and large molecule analysis using the ultrasensitive Single Molecule Counting (SMC™) Technology. We offer a menu of MilliporeSigma SMC™ ultrasensitive biomarker assays and provide the following services:

  • Biomarker Quantitation
  • Pharmacokinetics and Pharmacodynamics (PK/PD)
  • Immunogenicity (ADA)
  • Assay Development

SMC™ Technology Workflow
The SMC™ Technology provides enhanced quantification at both low and high levels of expression. The immunoassay uses traditional ELISA technology, combined with a unique assay elution step. The eluted fluorescently labeled detection antibodies are digitally counted on the SMCxPRO™ and the data is computed against a known concertation providing a quantitative measurement of the target analytes in the biological sample (e.g., CSF, serum, plasma).

With the SMCxPRO™ platform, you can detect extremely low-levels of established disease biomarkers, capturing concentrations down to the femtogram/mL level, and as a result monitor small changes in protein concentrations to accurately measure biomarkers associated with disease progression.

In addition, the small sample volume requirements allow you to conserve valuable samples, reduce program costs and improve productivity.

Please contact us with any inquiry and we would be delighted to assist you.

^ Top

 

smc

Verification Criteria for SMC™ Immunoassays
The SMC™ high sensitivity detection system addresses the needs of researchers who require highly quantitative, accurate, and robust biomarker assays. Our assays are rigorously developed and tested in matrix by multiple operators over multiple days.

A comprehensive set of criteria evaluating ultimate quantitative performance are used to qualify verified immunoassays, including:

Lower Limit of Quantification
Lowest point on the standard curve where CV is <20% and accuracy is within 20% of expected values.

Inter- and Intra- Assay Precision
Same samples run on multiple plates over multiple days to ensure reproducibility. Spiked and un-spiked samples report values within 20% across experiments.

Spike Recovery
Analyte added at the lower end of the standard curve to ensure accurate measurements for real samples. Minimum of 10 samples spiked with acceptable recovery between 80-120%.

Dilutional Linearity
Spiked samples diluted through at least 3 dilutions. Minimum of 10 samples spiked and diluted with acceptable recovery between 80-120%.

Dynamic Range
Assays target a quantifiable range of 3-4 logs.

Endogenous Range
Minimum of 10 samples from individual donors assessed for ability to quantify baseline biomarker levels.

Learn more about SMC™ technology at SigmaAldrich.com/smc


MilliporeSigma SMCTM Assay Offering the analysis of the following Analytes
Key: H=Human; M=Mouse; R=Rat; GP=Guinea Pig; Cy=Cynomolgus Monkey; C=Canine

Analyte

LLoQ 
(pg/mL)1

Standard Curve Range (pg/mL)

Median Endogenous (pg/mL)2

Species3

Sample Types4

Sample volume (μL)

Phospho-α-Synuclein(Ser129)6,7

0.1

0.05-50

P: 2.74
S:  1.81
C:  0.64

H

P,S,C

20, 20, 50

Total-α-Synuclein6,7

1.95

0.49-500

P: 1885
S: 1240
C: 233

H

P,S,C

0.5, 0.5, 10

Phospho-Akt1 (Ser473) 

0.98

1.0-1000

NA

H, M, R

L

varies8

Total Akt1 

7.80

1.0-1000

NA

H, M, R

L

varies8

Amyloid beta 1-406,7 

5.86

2.93-3000

Normal CSF:  1366
P:  152

H, M, R

C, P

5, 25

Amyloid beta 1-426,7 

0.98

0.24-250

Normal CSF:  192
P:  15

H, M, R

C, P

5, 25

BDNF6,7

0.04

0.02-100

P:  783
S:  410
CSF:  0.13

H

C, P, S

100, 1, 1

cTnI 6,7

0.69

0.17-600

P:  3.04
S: 3.02

H, Cy, R, C, GP

P, S

100

G-CSF 

0.08

0.02-20

17

H

P

10

GFAP6,7

0.12

0.06-300

P: 1.91
S: 1.93
C: 42.57

H

C, P, S

3.3, 100, 100

GLP-1 (active) 

0.40

0.05-50

3.46

H, M, R, C

P

100

GLP-1 (total) 

0.39

0.20-200

17.8

H, M, R, C

P

20

Glucagon6,7

0.78

0.20-200

44

H, M, R

P

10

GM-CSF 

0.02

0.005-5

0.2

H

P

100

IFN-α26,7

0.031

0.015-80

P: 0.08
S: 0.08

H

P,S

100

IFN-β1 

0.15

0.07-170

P: 0.35
S: 0.64

H

P,S

50

IFN-γ6,7

0.03

0.016-25

P:  1.4
S:  1.4

H

P, S

25

IL-1α26,7

0.12

0.06-60

P:  0.09
S:  0.10

H

P,S

100

IL-1β6,7

0.20

0.05-50

P:  0.11
S: 0.12

H

P,S

100

IL-2 (new version) 

0.09

0.02-80

0.21

H

P, S

100

IL-21 

0.20

0.11-250

0.53

H

S

50

IL-226,7

0.10

0.05-50

P:  1.51
S:  1.52

H

P,S

25

IL-236,7

0.10

0.1-100

P:  0.65
S:  0.46

H

P,S

100

IL-46,7

0.04

0.01-10

P:  0.18
S:  0.18

H

P,S

100

IL-56,7

0.04

0.05-50

P: 0.37
S:0.30

H

P,S

100

IL-66,7

0.08

0.01-50

P:  0.70
S: 0.69

H

P, S

75

IL-7 

0.39

0.10-100

4.91

H

P, S

50

IL-8 / CXCL8 

0.24

0.24-250

3.6

H

P, S

50

IL-106,7

0.10

0.10-100

P:  0.90
S:  0.89

H

P,S

100

IL-12p706,7

0.05

0.05-50

P:  0.29
S:  0.28

H

P, S

100

IL-136,7

0.04

0.02-100

P:  0.37
S:  0.33

H

P,S

100

IL-15 

0.10

0.02-25

3.38

H

P, S

100

IL-17A/F Heterodimer6,7

1.17

0.60-600

P:  1.36
S:  3.20

H

P,S

50

IL-17A6,7

0.07

0.02-60

P:  0.31
S:  0.30

H

P, S

50

IL-17F6,7

0.20

0.10-100

P:  1.10
S:  1.18

H

P, S

50

IL-186,7

0.09

0.04-100

P: 138
S: 145

H

P,S

10

KIM-15

3.91

1.0-1000

P: 65
S: 75
U: 147

H

P, S, U

25, 25, 5

MCP-16,7

0.15

0.06-400

P: 682
S: 1021

H

P,S

1.56

NGFβ6,7

0.017

0.09-200

P: 1.20
S: 0.92

H

P,S

50

NPTX26,7

0.58

0.29-1000

P: 8268
S: 8161
C: 1677

H

P,S,C

0.1, 0.1, 0.3

Phospho-Tau(Thr181)6,7

0.94

0.23-240

P: 3.4
S: 2.0
C: 21

H

P,S,C

50, 100, 25

Total Tau6,7

2.34

1.17-1200

P: 27.1
S: 7.0
C: 88.91

H

P,S,C

50, 100, 25

TNFα 

0.40

0.05-50

38.6

M

S

25

TNFα6,7

0.20

0.05-50

P:  0.85
S:  0.78

H

P,S

100

TSLP6,7

1.56

0.78-800

P: 5.04
S: 3.86

H

P,S

100

UCHL16,7

2.60

1.30-2000

P: 22.06
S: 20.49
C: 413

H

P,S,C

25,25,5

VEGF-A6,7

0.20

0.10-100

P:  48
S:  50

H

P,S

25

SARS-CoV-2 RBD IgG 

NA9

NA9

NA9

H

P,S

2

SARS-CoV-2 S1 IgA 

NA9

NA9

NA9

H

P,S

2

1 - LLoQ: Lowest point on standard curve that meets the following criteria for all sample types claimed: CV < 20% and accuracy within 20% of expected values, reproducible across at least three assay runs across three different operators.
2 - Median Endogenous: Minimum of 10 samples from individual donors assessed for ability to quantify baseline biomarker values.
3 - Optimized for first species type listed. Other listed species have been tested, but not optimized for peak performance.
4 - Optimized for use in sample type(s) listed. Key: P=Plasma; S=Serum; L=Lysate; U=Urine; C=Cerebrospinal Fluid (CSF)
5 - Plate-based assay
6 - Assay characteristic data is representative for both Erenna® and SMCxPRO™.
7 - Streamlined format kit.
8 - Sample volume varies based on dilution factor selected by user
9 - Qualitative assay

 

 

 

^ Top


 

 

StepOnePlus™ Real-Time PCR System

 

qPCR Services
StepOnePlus2Our laboratory utilizes the Applied Biosystems StepOne PlusTM Real-Time PCR system. We have extensive experience designing and performing qPCR assays using both TaqMan and SYBR green detection chemistries.

Our qPCR workflow involves RNA extraction and QC, cDNA conversion, primer design and validation (if necessary), reference gene optimization and data analysis. Our SYBR Green primer design and validation service involves optimization for amplicon size and primer specificity using both gel electrophoresis and melting curve analysis. We also perform an analysis of the efficiency of amplification for our designed primer sets. Our gene expression analysis generates a report detailing differential gene expression across the dataset using the comparative Ct methodology between control and treated samples.



PCR


Using real-time PCR, you can easily analyze the expression of a group of genes. The picture above is an example of treated LC-11 cells that were run using Qiagens' Human Fibrosis RT2Profile PCR Array.

 

 

^ Top